Italian GP Alto Partners has acquired an 80% stake in Italy-based Officina Farmaceutica Italiana (OFI), a family-owned contract manufacturer of dermo-cosmetic and nutritional products, and medical devices.
The GP acquired the stake in the business via its Alto Capital IV fund, which closed on €210m in April this year. The vehicle targets companies generating revenues in the €20-80m bracket.
The partnership will have the objective of fostering product development and help the company expand via acquisitions of smaller companies in the sector. Alberto Donati, the son of OFI's founder, will remain the chairman of the company.
Founded by Attilio Donati in 1946, OFI produces dermo-cosmetic and dietary products, and medical devices, on behalf of third parties and for its own brands.
Based in Bergamo, OFI generates a €18m turnover. According to the Italian online newschannel Be Beez, the group has an EBITDA margin of 16%.
Officina Farmaceutica Italiana – Alberto Donati (chairman).
Startup focuses on developing therapies against viral infections
GP invested in the gastronomy group via its first fund, which focuses on "living heritage" companies
Restructuring plan includes the acquisition of all the shares of Maccaferri
Hyperion's management team and employees will remain the largest shareholder group in the company